Impact of epithelial ovarian cancer screening on patient-relevant outcomes in average-risk postmenopausal women

  • Protocol
  • Intervention

Authors

  • Christoph G Mosch,

    Corresponding author
    1. University Witten/Herdecke, Institute for Research in Operative Medicine (IFOM) - Department for Evidence-based Health Services Research, Cologne, Germany
    • Christoph G Mosch, Institute for Research in Operative Medicine (IFOM) - Department for Evidence-based Health Services Research, University Witten/Herdecke, Cologne, Germany. christoph.mosch@uni-wh.de.

    Search for more papers by this author
  • Thomas Jaschinski,

    1. University Witten/Herdecke, Institute for Research in Operative Medicine (IFOM) - Department for Evidence-based Health Services Research, Cologne, Germany
    Search for more papers by this author
  • Michaela Eikermann

    1. University Witten/Herdecke, Institute for Research in Operative Medicine (IFOM) - Department for Evidence-based Health Services Research, Cologne, Germany
    Search for more papers by this author

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The purpose of this systematic review is to identify and summarise the results of randomised controlled trials that assess the benefits and harms of transvaginal sonography or other screening measures (e.g. serum CA-125 or HE4) and multimodal testing, for ovarian cancer screening in asymptomatic postmenopausal women with an average EOC risk by evaluating the screening-related patient-relevant outcomes (e.g. EOC-specific mortality rates).